GCC19CART

Lyell Immunopharma, Inc. · Phase 1 active Small molecule

At a glance

Generic name	GCC19CART
Sponsor	Lyell Immunopharma, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

GCC19CART for Patients With Metastatic Colorectal Cancer (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GCC19CART CI brief — competitive landscape report
GCC19CART updates RSS · CI watch RSS
Lyell Immunopharma, Inc. portfolio CI